Recombinant Anti-DNMT1 x Anti-SHH Bispecific Antibody (CrossMab)
TypeName: Business Offer
Category:
Offer Date:2019/07/07
Country: United States
Summary: Recombinant Anti-DNMT1 x Anti-SHH Bispecific Antibody (CrossMab) is designed to be expressed as four chains with knobs-into-holes mutations and domain crossover. After one or multi-steps purification, high-purity antibody can be obtained. This BsAb can bind two factors simultaneously, block Hedgehog binding to PTCH, downregulate of DNMT1 and block DNA methylation. It is designed for the research of Hormone refractory breast cancer (HRBC) therapy.https://www.creative-biolabs.com/bsab/symbolsearch-dnmt1%2520%2526%2520shh.htm
Agriculture & Food
Business Services
Electronics, IT and Telecoms
Leisure & Tourism
Minerals
Textiles, Clothing, Leather,
Transport & Logistics
